Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study

Table 4 Number of patients with hypoglycemia

Number of patients	Repaglinide and clopidogrel group	Mitiglinide and clopidogrel group	Repaglinide group
Number of patients	(N = 15)	(N = 15)	(N = 15)
Patients with hypoglycemia	6 (40.0%)*	1 (6.7%)	0 (0.0%)

Differences of hypoglycemia incidence rates in “repaglinide group versus repaglinide and clopidogrel group” and “repaglinide and clopidogrel group versus mitiglinide and clopidogrel group” were analyzed by Fisher’s exact test using Bonferroni’s adjusted significant level
*p < 0.05 for the repaglinide group versus repaglinide and clopidogrel group

ISSN: 2055-0294